Clinical Trial Update: Intravenous Lidocaine in Carcinologic ENT Surgery: A Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain (ELICO) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on intravenous lidocaine for opioid-sparing strategies and reduction of chronic post-surgical pain in carcinologic ENT surgery. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Carcinologic Ear, Nose, and Throat (ENT) Surgery | Phase 3 | Status: COMPLETED